Benzinga | Jul 19, 2021 07:31AM EDT

Canaccord Genuity Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $64

Canaccord Genuity analyst Richard Close initiates coverage on Doximity (NYSE:DOCS) with a Buy rating and announces Price Target of $64.